Researchers at the University of Maryland School of Medicine have identified a fish peptide, or protein, derived from Pacific cod that may inhibit prostate cancer and possibly other cancers from spreading, according to preclinical research published online in the Proceedings of the National Academy of Sciences.
“The use of natural dietary products with anti-tumor activity is an important and emerging field of research,” says senior author Hafiz Ahmed, Ph.D., assistant professor of biochemistry and molecular biology at the University of Maryland School of Medicine and scientist at the Institute for Marine and Environmental Technology (IMET). “Understanding how these products work could allow us to develop foods that also act as cancer therapeutics and agents for immunotherapy.”
New sports nutrition product launches containing a new hydrolyzed fish protein are imminent, says Bluewave Marine Ingredients as it brings its branded AminoMarine ingredient to market.
Scanbio Marine Group AS (“Scanbio”), a leading producer of fish protein concentrate, fish meal and fish oil from fresh and fresh preserved fish by-products, recently announced that it has entered into a definitive agreement to acquire Tank og Masse-Transport AS (“TMT”) and Haugland Sjotransport AS (“HS”), two independently owned and operated Norwegian companies that collect, store and transport fish by-product from aquaculture fisheries and fish processing facilities in Norway. The transactions, which are subject to customary closing conditions, are expected to close in the fourth quarter of 2012. Financial terms were not disclosed.
TMT collects, stores and transports category-2 (“K2″) and category-3 (“K3″) fish by-product from aquaculture fisheries and fish processing facilities in Norway. HS owns two state-of-the-art vessels, the Haugfjord and Haugbas, which are leased to TMT. The two vessels are expected to complement Scanbio’s current fleet.
TMT and HS are majority owned by Ole and Kenneth Haugland , who will continue to work with Scanbio after the closing of the transactions.
Water extract from the Haruan fish in Malaysia has proved safe and effective for healing incision and burn wounds.
Haruan is a popular fish to eat in Malaysia and is thought to have wound healing properties due to the abundance of fatty and amino acids, which help blood clotting and reduce pain. When prepared as fillets, researchers cook the fish using distilled water in a pressure cooker. The fillets are discarded and the water extract left over is compounded into an aerosol spray.
Rabbits, mice and rats were used to examine Haruan water extract’s effect on skin, and the animals were then treated for incision and burn wounds with the extract in aerosol form. Two aerosol formulas were made using the water extract, one with fusidic acid and the other without. Those treated with the fusidic acid spray had a slower healing time as it inhibited the growth of scar tissue. Like many topical antibiotics, it is thought that fusidic acid is harmful to the wound healing cells.
The Haruan water extract spray without fusidic acid, however, was far more effective in helping collagen proliferate and fibroblast production. Specifically in burn wounds the spray keeps the wound site cool, reducing inflammation.
Paine & Partners, LLC (“Paine & Partners”), a global private equity investment firm, today announced that it has entered into a definitive agreement to acquire Scanbio Marine Group (“Scanbio”), a leading producer of fish protein concentrate, fish meal and fish oil from fresh and ensiled fish by-products from Scanbio AS, which is owned by Rolf Eide, Per Arne Eide, Nordic secondary direct fund Verdane Capital IV (“Verdane Capital Advisors”) and certain other shareholders.
The transaction is expected to close in the third quarter of 2011. Financial terms of the transaction were not disclosed.
Scanbio is headquartered in Trondheim, Norway, and its fish protein concentrate, fish meal and fish oil are produced from white and pelagic fish and salmon by-products and are primarily sold into the aquaculture fish feed, animal feed and bio-fuel markets. Scanbio’s business addresses the growing global market demand for protein ingredients for animal feed sourced from the sustainable processing of fish by-products.
Following the Paine & Partners transaction, Carl Eide will assume the position of Chief Executive Officer of Scanbio. Per Arne Eide will retire as Chief Executive Officer, but will remain involved with the company and will have a seat on the Scanbio Board of Directors.
Long-chain monounsaturated fatty acids from fish sources may improve insulin sensitivity and reduce risk factors associated with metabolic syndrome, according to new research in mice.
The study, published in the Journal of Agricultural and Food Chemistry, reports that blood plasma glucose, insulin, and lipid concentrations are enhanced, whilst insulin sensitivity is improved in mice fed a diet rich in marine derived long-chain monounsaturated fatty acids (MUFAs).
“This study demonstrates that fish-oil-derived MUFA ingestion reduces insulin resistance, as judged by the insulin tolerance test, and attenuates metabolic syndrome by improving hyperglycemia, hyperinsulinemia, and hyperlipidemia,” wrote the study authors, led by Zhi-Hong Yang, from the Tokyo Innovation Center, Japan.
“Furthermore, intake of MUFA decreased obesity-induced inflammation by suppressing … inflammatory marker genes and arachidonic acid levels, thereby possibly, in turn, reducing insulin resistance in diet-induced obese mice,” they added.
Bluewave Marine Ingredients Announces Commissioning of Food Grade, Fish Protein Isolate (FPI) Production Plant in PeruPosted On: June 2, 2011
This facility is being touted as the first of its kind in the world, mass producing fat‐free, membrane refined, Fish Protein and Fish Peptide products for human consumption applications.
The $6MM facility has been awarded its Sanitary License by the Peruvian Sanitary Authority, Instituto Tecnologica Pesquera (ITP), and will begin exporting and selling locally commercial quantities in June 2011.
Bluewave Marine Ingredients is expanding its Asia Pacific distribution network with the appointment of Nice Garden as distributor of PerfectDigest products for the Taiwan market.
“Nice Garden has exceptional knowledge of the Taiwan market and we believe that with their excellent distribution network, manufacturing capabilities and professionalism they will provide excellent market coverage for the PerfectDigest range,” said Mark Rottmann, COO of Bluewave. ”Taiwan is an important market with great potential as well as being the base of operations for leading companies in the Asia Pacific.”
Aurora Algae recently introduced the A2 product portfolio, a series of natural products derived from its proprietary algae platform. The A2 product portfolio is uniquely sustainable, scalable, and flexible to address growing demand in the explosive nutrition, aquaculture, pharmaceutical, and energy markets
A2 Omega-3™ is a family of Omega-3 oils aimed at the nutraceutical and pharmaceutical markets with the goal of providing a natural, sustainable and cost-effective alternative to fish oil and fermented products. The first offering in this family, A2 EPA Pure™ will make the benefits of EPA available to a broader market since it is derived from an allergen-free, vegetarian source.
A growing body of research indicates the potential for the marine environment as a unique source of functional food ingredients. But what makes them unique? How can they be used in foods? And what are the benefits of using them?
Marine Ingredients: Oceans of Opportunity will explore these questions and equip delegates with an improved technical and market understanding of marine ingredients as well as an insight into their application potential.